Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Home exercise program using mobile technology for patients with a HeartMate 3 device

Official title: Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

Run by University of Pennsylvania · NCT06291922 · Data updated 2026-11-12

This study is testing whether a home exercise program using mobile technology can help people with a HeartMate 3 device feel stronger and improve their quality of life compared to those who just get regular care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations4 sites (Detroit, Michigan and 3 other locations)
StatusRecruiting
StartedAugust 14, 2024
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedOctober 7, 2026
Trial IDNCT06291922 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have recently received a HeartMate 3 LVAD and can ambulate independently.

Probably not a fit

Patients with major comorbidities or limitations that interfere with exercise training, such as significant orthopedic or neurologic issues, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effects of a home-based exercise program utilizing mobile technology on patients who have recently received a HeartMate 3 left ventricular assist device (LVAD). Participants will be randomized into two groups: one receiving an individualized exercise intervention and the other receiving usual care. The study will assess various outcomes including physical activity, frailty, muscle mass, and quality of life through baseline measurements and ongoing monitoring using activity tracking devices. The intervention group will receive tailored exercise prescriptions and support, while the control group will be encouraged to increase their activity levels with standard care.

Why it matters

Potential benefit: If successful, this program could significantly improve physical activity levels, muscle mass, and overall quality of life for patients with LVADs.

How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in heart failure patients, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ≥ 18 years of age
2. Newly implanted with a HeartMate 3™ LVAD for the first time
3. Able to ambulate independently (with or without the use of an assistive device)
4. Owns a smartphone with Internet connection
5. Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge

Exclusion Criteria:

1\. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)

Where it's running

  • Henry Ford Health
    Detroit, Michigan, United States
    Recruiting
  • Cleveland Clinic Foundation
    Cleveland, Ohio, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Utah Health
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.